Publikationen Muskelzentrum Ruhrgebiet (Neurologische Univ

Publikationen Muskelzentrum Ruhrgebiet (Neurologische Univ

Publikationen Muskelzentrum Ruhrgebiet (Neurologische Univ.-Klinik Bergmannsheil)
Kley, RA, Tarnopolsky, MA, Vorgerd, M. Creatine for treating muscle disorders. Cochrane Database
Syst Rev. 2011(2):CD004760.
Schwenkreis, P, Voigt, M, Hasenbring, M, Tegenthoff, M, Vorgerd, M, Kley, RA. Central mechanisms
during fatiguing muscle exercise in muscular dystrophy and fibromyalgia syndrome: a study with
transcranial magnetic stimulation. Muscle Nerve. 2011. 43(4):479–484.
Schmidt, J, Vorgerd, M. Therapiestandard bei Myositiden und Muskeldystrophien. Nervenarzt. 2011.
82(6):723–732.
Maetzler, W, Reimold, M, Schittenhelm, J, Vorgerd, M, Bornemann, A, Kötter, I, Pfannenberg, C,
Reischl, G, Schöls, L. Increased [11C]PIB-PET levels in inclusion body myositis are indicative of
amyloid beta deposition. J. Neurol. Neurosurg. Psychiatr. 2011. 82(9):1060–1062.
Jacobi, C, Ruscheweyh, R, Vorgerd, M, Weber, M, Storch-Hagenlocher, B, Meinck, HM. Rippling
muscle disease: variable phenotype in a family with five afflicted members. Muscle Nerve. 2010.
41(1):128–132.
Linnemann, A, van der Ven, PFM, Vakeel, P, Albinus, B, Simonis, D, Bendas, G, Schenk, JA, Micheel,
B, Kley, RA, Fürst, DO. The sarcomeric Z-disc component myopodin is a multiadapter protein that
interacts with filamin and alpha-actinin. Eur. J. Cell Biol. 2010. 89(9):681–692.
Schroers, R, Baraniskin, A, Heute, C, Vorgerd, M, Brunn, A, Kuhnhenn, J, Kowoll, A, Alekseyev, A,
Schmiegel, W, Schlegel, U, Deckert, M, Pels, H. Diagnosis of leptomeningeal disease in diffuse large
B-cell lymphomas of the central nervous system by flow cytometry and cytopathology. Eur. J.
Haematol. 2010. 85(6):520–528.
Klauke, B, Kossmann, S, Gaertner, A, Brand, K, Stork, I, Brodehl, A, Dieding, M, Walhorn, V,
Anselmetti, D, Gerdes, D, Bohms, B, Schulz, U, Knyphausen, E zu, Vorgerd, M, Gummert, J, Milting,
H. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular
cardiomyopathy. Hum. Mol. Genet. 2010. 19(23):4595–4607.
Guettsches, A, Kuechler, A, Gal, A, Schmitz, W, Tegenthoff, M, Vorgerd, M. Female carriers of Xchromosomal adrenoleukodystrophy: a major differential diagnosis in progressive myelopathy. J.
Neurol. 2010. 257(8):1394–1395.
Peters, SA, Kley, R, Tegenthoff, M, Vorgerd, M, Nicolas, V, Heyer, CM. MRI in lipid-lowering agentassociated myopathy: a retrospective review of 21 cases. AJR Am J Roentgenol. 2010.
194(4):W323-8.
Wattjes, MP, Kley, RA, Fischer, D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol.
2010. 20(10):2447–2460.
Joshi, PR, Gläser, D, Schmidt, S, Vorgerd, M, Winterholler, M, Eger, K, Zierz, S, Deschauer, M.
Molecular diagnosis of German patients with late-onset glycogen storage disease type II. J. Inherit.
Metab. Dis. 2008. 31 Suppl 2:S261-5.
Strach, K, Sommer, T, Grohé, C, Meyer, C, Fischer, D, Walter, MC, Vorgerd, M, Reilich, P, Bär, H,
Reimann, J, Reuner, U, Germing, A, Goebel, HH, Lochmüller, H, Wintersperger, B, Schröder, R.
Clinical, genetic, and cardiac magnetic resonance imaging findings in primary desminopathies.
Neuromuscul. Disord. 2008. 18(6):475–482.
Kley, RA, Tarnopolsky, MA, Vorgerd, M. Creatine treatment in muscle disorders: a meta-analysis of
randomised controlled trials. J. Neurol. Neurosurg. Psychiatr. 2008. 79(4):366–367.
Fischer, D, Kley, RA, Strach, K, Meyer, C, Sommer, T, Eger, K, Rolfs, A, Meyer, W, Pou, A, Pradas, J,
Heyer, CM, Grossmann, A, Huebner, A, Kress, W, Reimann, J, Schröder, R, Eymard, B, Fardeau, M,
Udd, B, Goldfarb, L, Vorgerd, M, Olivé, M. Distinct muscle imaging patterns in myofibrillar myopathies.
Neurology. 2008. 71(10):758–765.
Nolte, KW, Janecke, AR, Vorgerd, M, Weis, J, Schröder, JM. Congenital type IV glycogenosis: the
spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel
mutations in the GBE1 gene. Acta Neuropathol. 2008. 116(5):491–506.
Peters, SA, Köhler, C, Schara, U, Hohendahl, J, Vorgerd, M, Nicolas, V, Heyer, CM. Myopathien im
Kindesalter - Evaluation mittels Kernspintomografie der Muskulatur. Klin Padiatr. 2008. 220(1):37–46.
Vorgerd, M. Therapeutic options in other metabolic myopathies. Neurotherapeutics. 2008. 5(4):579–
582.
Roggenland, D, Heyer, CM, Vorgerd, M, Nicolas, V. Das Nervus-interosseus-anterior-Syndrom (KilohNevin-Syndrom)--Diagnostik mittels MRT. Rofo. 2008. 180(6):561–562.
Kohlhaas, K, Brechmann, T, Vorgerd, M. Hepatitis-B-assoziierte Panarteriitis nodosa mit zerebraler
Vaskulitis. Dtsch. Med. Wochenschr. 2007. 13234-35:1748–1752.
Löwe, T, Kley, RA, van der Ven, PFM, Himmel, M, Huebner, A, Vorgerd, M, Fürst, DO. The
pathomechanism of filaminopathy: altered biochemical properties explain the cellular phenotype of a
protein aggregation myopathy. Hum. Mol. Genet. 2007. 16(11):1351–1358.
Kley, RA, Vorgerd, M, Tarnopolsky, MA. Creatine for treating muscle disorders. Cochrane Database
Syst Rev. 2007(1):CD004760.
Kley, RA, Hellenbroich, Y, van der Ven, PFM, Fürst, DO, Huebner, A, Bruchertseifer, V, Peters, SA,
Heyer, CM, Kirschner, J, Schröder, R, Fischer, D, Müller, K, Tolksdorf, K, Eger, K, Germing, A,
Brodherr, T, Reum, C, Walter, MC, Lochmüller, H, Ketelsen, U, Vorgerd, M. Clinical and morphological
phenotype of the filamin myopathy: a study of 31 German patients. Brain. 2007. 130Pt 12:3250–3264.
Zhang, Q, Bethmann, C, Worth, NF, Davies, JD, Wasner, C, Feuer, A, Ragnauth, CD, Yi, Q, Mellad,
JA, Warren, DT, Wheeler, MA, Ellis, JA, Skepper, JN, Vorgerd, M, Schlotter-Weigel, B, Weissberg, PL,
Roberts, RG, Wehnert, M, Shanahan, CM. Nesprin-1 and -2 are involved in the pathogenesis of
Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum. Mol. Genet.
2007. 16(23):2816–2833.
Walter, MC, Reilich, P, Huebner, A, Fischer, D, Schröder, R, Vorgerd, M, Kress, W, Born, C, Schoser,
BG, Krause, KH, Klutzny, U, Bulst, S, Frey, JR, Lochmüller, H. Scapuloperoneal syndrome type
Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the
desmin mutation R350P. Brain. 2007. 130Pt 6:1485–1496.
Diers, A, Carl, M, Stoltenburg-Didinger, G, Vorgerd, M, Spuler, S. Painful enlargement of the calf
muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous
mutation in DYSF. Neuromuscul. Disord. 2007. 17(2):157–162.
Vorgerd, M, Zange, J. Treatment of glycogenosys type V (McArdle disease) with creatine and
ketogenic diet with clinical scores and with 31P-MRS on working leg muscle. Acta Myol. 2007.
26(1):61–63.
Deschauer, M, Morgenroth, A, Joshi, PR, Gläser, D, Chinnery, PF, Aasly, J, Schreiber, H, Knape, M,
Zierz, S, Vorgerd, M. Analysis of spectrum and frequencies of mutations in McArdle disease.
Identification of 13 novel mutations. J. Neurol. 2007. 254(6):797–802.
Horvath, R, Kley, RA, Lochmüller, H, Vorgerd, M. Parkinson syndrome, neuropathy, and myopathy
caused by the mutation A8344G (MERRF) in tRNALys. Neurology. 2007. 68(1):56–58.
Schroers, A, Kley, RA, Stachon, A, Horvath, R, Lochmüller, H, Zange, J, Vorgerd, M. Gentamicin
treatment in McArdle disease: failure to correct myophosphorylase deficiency. Neurology. 2006.
66(2):285–286.
Hoffjan, S, Thiels, C, Vorgerd, M, Neuen-Jacob, E, Epplen, JT, Kress, W. Extreme phenotypic
variability in a German family with X-linked myotubular myopathy associated with E404K mutation in
MTM1. Neuromuscul. Disord. 2006. 16(11):749–753.
Peters, S, Vorgerd, M, Heyer, CM. Chronisch progressive externe Ophthalmoplegie plus: Diagnostik
durch Muskelkernspintomographie. Rofo. 2006. 178(10):1030–1032.
Meyer, C, Carlqvist, H, Vorgerd, M, Schöls, L, Ostenson, C, Ristow, M. Regular insulin secretory
oscillations despite impaired ATP synthesis in Friedreich Ataxia patients. Horm. Metab. Res. 2006.
38(10):683–687.
Hagen, M von der, Schallner, J, Kaindl, AM, Koehler, K, Mitzscherling, P, Abicht, A, Grieben, U,
Korinthenberg, R, Kress, W, Moers, A von, Müller, JS, Schara, U, Vorgerd, M, Walter, MC, MüllerReible, C, Hübner, C, Lochmüller, H, Huebner, A. Facing the genetic heterogeneity in neuromuscular
disorders: linkage analysis as an economic diagnostic approach towards the molecular diagnosis.
Neuromuscul. Disord. 2006. 16(1):4–13.
Endo, Y, Horinishi, A, Vorgerd, M, Aoyama, Y, Ebara, T, Murase, T, Odawara, M, Podskarbi, T, Shin,
YS, Okubo, M. Molecular analysis of the AGL gene: heterogeneity of mutations in patients with
glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey. J. Hum.
Genet. 2006. 51(11):958–963.
Engelfried, K, Vorgerd, M, Hagedorn, M, Haas, G, Gilles, J, Epplen, JT, Meins, M. Charcot-MarieTooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2). BMC Med. Genet. 2006.
7:53.
Rommel, O, Kley, RA, Dekomien, G, Epplen, JT, Vorgerd, M, Hasenbring, M. Muscle pain in
myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related
coping. Pain. 2006. 124(3):295–304.
Saft, C, Zange, J, Andrich, J, Müller, K, Lindenberg, K, Landwehrmeyer, B, Vorgerd, M, Kraus, PH,
Przuntek, H, Schöls, L. Mitochondrial impairment in patients and asymptomatic mutation carriers of
Huntington's disease. Mov. Disord. 2005. 20(6):674–679.
Jenne, DE, Kley, RA, Vorgerd, M, Schröder, JM, Weis, J, Reimann, H, Albrecht, B, Nürnberg, P,
Thiele, H, Müller, CR, Meng, G, Witt, CC, Labeit, S. Limb girdle muscular dystrophy in a sibling pair
with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3. Biol.
Chem. 2005. 386(1):61–67.
Bär, H, Fischer, D, Goudeau, B, Kley, RA, Clemen, CS, Vicart, P, Herrmann, H, Vorgerd, M, Schröder,
R. Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin
intermediate filaments in vivo and in vitro. Hum. Mol. Genet. 2005. 14(10):1251–1260.
Schöls, L, Zange, J, Abele, M, Schillings, M, Skipka, G, Kuntz-Hehner, S, van Beekvelt, MCP, Colier,
WNJM, Müller, K, Klockgether, T, Przuntek, H, Vorgerd, M. L-carnitine and creatine in Friedreich's
ataxia. A randomized, placebo-controlled crossover trial. J Neural Transm. 2005. 112(6):789–796.
Clemen, CS, Fischer, D, Roth, U, Simon, S, Vicart, P, Kato, K, Kaminska, AM, Vorgerd, M, Goldfarb,
LG, Eymard, B, Romero, NB, Goudeau, B, Eggermann, T, Zerres, K, Noegel, AA, Schröder, R. Hsp272D-gel electrophoresis is a diagnostic tool to differentiate primary desminopathies from myofibrillar
myopathies. FEBS Lett. 2005. 579(17):3777–3782.
Kornblum, C, Schröder, R, Müller, K, Vorgerd, M, Eggers, J, Bogdanow, M, Papassotiropoulos, A,
Fabian, K, Klockgether, T, Zange, J. Creatine has no beneficial effect on skeletal muscle energy
metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind
31P-MRS crossover study. Eur. J. Neurol. 2005. 12(4):300–309.
Schulte-Mattler, WJ, Kley, RA, Rothenfusser-Korber, E, Böhm, S, Brüning, T, Hackemann, J,
Steinbrecher, A, Düring, MV, Voss, B, Vorgerd, M. Immune-mediated rippling muscle disease.
Neurology. 2005. 64(2):364–367.
Busch, V, Gempel, K, Hack, A, Müller, K, Vorgerd, M, Lochmüller, H, Baumeister, FAM. Treatment of
glycogenosis type V with ketogenic diet. Ann. Neurol. 2005. 58(2):341.
Vorgerd, M, van der Ven, PFM, Bruchertseifer, V, Löwe, T, Kley, RA, Schröder, R, Lochmüller, H,
Himmel, M, Koehler, K, Fürst, DO, Huebner, A. A mutation in the dimerization domain of filamin c
causes a novel type of autosomal dominant myofibrillar myopathy. Am. J. Hum. Genet. 2005.
77(2):297–304.
Walter, MC, Petersen, JA, Stucka, R, Fischer, D, Schröder, R, Vorgerd, M, Schroers, A, Schreiber, H,
Hanemann, CO, Knirsch, U, Rosenbohm, A, Huebner, A, Barisic, N, Horvath, R, Komoly, S, Reilich, P,
Müller-Felber, W, Pongratz, D, Müller, JS, Auerswald, EA, Lochmüller, H. FKRP (826CA) frequently
causes limb-girdle muscular dystrophy in German patients. J. Med. Genet. 2004. 41(4):e50.
Arning, L, Jagiello, P, Schara, U, Vorgerd, M, Dahmen, N, Gencikova, A, Mortier, W, Epplen, JT,
Gencik, M. Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular
dystrophies as determined by qRT-PCR. J. Neurol. 2004. 251(1):72–78.
Züchner, S, Vorgerd, M, Sindern, E, Schröder, JM. The novel neurofilament light (NEFL) mutation
Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-MarieTooth neuropathy. Neuromuscul. Disord. 2004. 14(2):147–157.
Zange, J, Grehl, T, Disselhorst-Klug, C, Rau, G, Müller, K, Schröder, R, Tegenthoff, M, Malin, J,
Vorgerd, M. Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: a
noninvasive 31P-MRS and EMG study. Muscle Nerve. 2003. 27(6):728–736.
Kubisch, C, Schoser, BGH, Düring, M von, Betz, RC, Goebel, H, Zahn, S, Ehrbrecht, A, Aasly, J,
Schroers, A, Popovic, N, Lochmüller, H, Schröder, JM, Brüning, T, Malin, J, Fricke, B, Meinck, H,
Torbergsen, T, Engels, H, Voss, B, Vorgerd, M. Homozygous mutations in caveolin-3 cause a severe
form of rippling muscle disease. Ann. Neurol. 2003. 53(4):512–520.
Walter, MC, Braun, C, Vorgerd, M, Poppe, M, Thirion, C, Schmidt, C, Schreiber, H, Knirsch, UI,
Brummer, D, Müller-Felber, W, Pongratz, D, Müller-Höcker, J, Huebner, A, Lochmüller, H. Variable
reduction of caveolin-3 in patients with LGMD2B/MM. J. Neurol. 2003. 250(12):1431–1438.
Fischer, D, Schroers, A, Blümcke, I, Urbach, H, Zerres, K, Mortier, W, Vorgerd, M, Schröder, R.
Consequences of a novel caveolin-3 mutation in a large German family. Ann. Neurol. 2003.
53(2):233–241.
Burwinkel, B, Hu, B, Schroers, A, Clemens, PR, Moses, SW, Shin, YS, Pongratz, D, Vorgerd, M,
Kilimann, MW. Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1,
PHKG1 or six other candidate genes explain only a minority of cases. Eur. J. Hum. Genet. 2003.
11(7):516–526.
Sindern, E, Ziemssen, F, Ziemssen, T, Podskarbi, T, Shin, Y, Brasch, F, Müller, KM, Schröder, JM,
Malin, J, Vorgerd, M. Adult polyglucosan body disease: a postmortem correlation study. Neurology.
2003. 61(2):263–265.
Schara, U, Vorgerd, M, Popovic, N, Schoser, BGH, Ricker, K, Mortier, W. Rippling muscle disease in
childhood. J. Child Neurol. 2002. 17(7):483–490.
Vorgerd, M, Zange, J. Carbohydrate oxidation disorders of skeletal muscle. Curr Opin Clin Nutr
Metab Care. 2002. 5(6):611–617.
Vorgerd, M, Zange, J, Kley, R, Grehl, T, Hüsing, A, Jäger, M, Müller, K, Schröder, R, Mortier, W,
Fabian, K, Malin, J, Luttmann, A. Effect of high-dose creatine therapy on symptoms of exercise
intolerance in McArdle disease: double-blind, placebo-controlled crossover study. Arch. Neurol. 2002.
59(1):97–101.
Zange, J, Kornblum, C, Müller, K, Kurtscheid, S, Heck, H, Schröder, R, Grehl, T, Vorgerd, M. Creatine
supplementation results in elevated phosphocreatine/adenosine triphosphate (ATP) ratios in the calf
muscle of athletes but not in patients with myopathies. Ann. Neurol. 2002. 52(1):126; author reply
126-7.
Postler, E, Sindern, E, Vorgerd, M, Schmitz, I, Malin, JP, Müller, KM. Letale Kardiomyopathie bei
adulter Polyglukosankörperkrankheit. Pathologe. 2002. 23(3):229–234.
Vorgerd, M, Gencik, M, Mortier, J, Epplen, JT, Malin, JP, Mortier, W. Isolated loss of gammasarcoglycan: diagnostic implications in autosomal recessive limb-girdle muscular dystrophies. Muscle
Nerve. 2001. 24(3):421–424.
Schöls, L, Vorgerd, M, Schillings, M, Skipka, G, Zange, J. Idebenone in patients with Friedreich ataxia.
Neurosci. Lett. 2001. 306(3):169–172.
Betz, RC, Schoser, BG, Kasper, D, Ricker, K, Ramírez, A, Stein, V, Torbergsen, T, Lee, YA, Nöthen,
MM, Wienker, TF, Malin, JP, Propping, P, Reis, A, Mortier, W, Jentsch, TJ, Vorgerd, M, Kubisch, C.
Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.
Nat. Genet. 2001. 28(3):218–219.
Vorgerd, M, Ricker, K, Ziemssen, F, Kress, W, Goebel, HH, Nix, WA, Kubisch, C, Schoser, BG,
Mortier, W. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation.
Neurology. 2001. 57(12):2273–2277.
Bonne, G, Mercuri, E, Muchir, A, Urtizberea, A, Bécane, HM, Recan, D, Merlini, L, Wehnert, M, Boor,
R, Reuner, U, Vorgerd, M, Wicklein, EM, Eymard, B, Duboc, D, Penisson-Besnier, I, Cuisset, JM,
Ferrer, X, Desguerre, I, Lacombe, D, Bushby, K, Pollitt, C, Toniolo, D, Fardeau, M, Schwartz, K,
Muntoni, F. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular
dystrophy due to mutations of the lamin A/C gene. Ann. Neurol. 2000. 48(2):170–180.
Vorgerd, M, Grehl, T, Jager, M, Muller, K, Freitag, G, Patzold, T, Bruns, N, Fabian, K, Tegenthoff, M,
Mortier, W, Luttmann, A, Zange, J, Malin, JP. Creatine therapy in myophosphorylase deficiency
(McArdle disease): a placebo-controlled crossover trial. Arch. Neurol. 2000. 57(7):956–963.
Schulz, JB, Dehmer, T, Schöls, L, Mende, H, Hardt, C, Vorgerd, M, Bürk, K, Matson, W, Dichgans, J,
Beal, MF, Bogdanov, MB. Oxidative stress in patients with Friedreich ataxia. Neurology. 2000.
55(11):1719–1721.
Hebinck, J, Hardt, C, Schöls, L, Vorgerd, M, Briedigkeit, L, Kahn, CR, Ristow, M. Heterozygous
expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans.
Diabetes. 2000. 49(9):1604–1607.
Ziemssen, F, Sindern, E, Schröder, JM, Shin, YS, Zange, J, Kilimann, MW, Malin, JP, Vorgerd, M.
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body
disease. Ann. Neurol. 2000. 47(4):536–540.
Bührer, C, van Landeghem, F, Brück, W, Felderhoff-Müser, U, Vorgerd, M, Obladen, M. Fetal-onset
severe skeletal muscle glycogenosis associated with phosphorylase-b kinase deficiency.
Neuropediatrics. 2000. 31(2):104–106.
Vorgerd, M, Schöls, L, Hardt, C, Ristow, M, Epplen, JT, Zange, J. Mitochondrial impairment of human
muscle in Friedreich ataxia in vivo. Neuromuscul. Disord. 2000. 10(6):430–435.
Ristow, M, Vorgerd, M, Möhlig, M, Schatz, H, Pfeiffer, A. Insulin resistance and impaired insulin
secretion due to phosphofructo-1-kinase-deficiency in humans. J. Mol. Med. 1999. 77(1):96–103.
Sindern, E, Patzold, T, Vorgerd, M, Shin, YS, Podskarbi, T, Schröder, JM, Malin, JP. Adulte
Polyglukosankörperkrankheit. Fallbeispiel mit überwiegender Beteiligung des zentralen und
peripheren Nervensystems und Branchingenzymdefekt in Leukozyten. Nervenarzt. 1999. 70(8):745–
749.
Schwenkreis, P, Vorgerd, M, Malin, JP, Tegenthoff, M. Assessment of postexcitatory inhibition in
patients with focal dystonia. Acta Neurol. Scand. 1999. 100(4):260–264.
Ristow, M, Carlqvist, H, Hebinck, J, Vorgerd, M, Krone, W, Pfeiffer, A, Müller-Wieland, D, Ostenson,
CG. Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of
insulin secretory oscillations. Diabetes. 1999. 48(8):1557–1561.
Vorgerd, M, Bolz, H, Patzold, T, Kubisch, C, Malin, JP, Mortier, W. Phenotypic variability in rippling
muscle disease. Neurology. 1999. 52(7):1453–1459.
Burwinkel, B, Kreuder, J, Schweitzer, S, Vorgerd, M, Gempel, K, Gerbitz, KD, Kilimann, MW. Carnitine
transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation
and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality. Biochem.
Biophys. Res. Commun. 1999. 261(2):484–487.
Voigt, E, Griga, T, Tromm, A, Henschel, MG, Vorgerd, M, May, B. Polymyositis of the skeletal muscles
as an extraintestinal complication in quiescent ulcerative colitis. Int J Colorectal Dis. 1999.
14(6):304–307.
Grehl, T, Müller, K, Vorgerd, M, Tegenthoff, M, Malin, JP, Zange, J. Impaired aerobic glycolysis in
muscle phosphofructokinase deficiency results in biphasic post-exercise phosphocreatine recovery in
31P magnetic resonance spectroscopy. Neuromuscul. Disord. 1998. 8(7):480–488.
Vorgerd, M, Benkmann, HG, Tegenthoff, M, Gal, A, Malin, JP. Adrenoleukodystrophie und
Adrenomyeloneuropathie. Klinische, biochemische und molekulargenetische Befunde. Nervenarzt.
1998. 69(2):174–179.
Liepert, J, Wessel, K, Schwenkreis, P, Trillenberg, P, Otto, V, Vorgerd, M, Malin, JP, Tegenthoff, M.
Reduced intracortical facilitation in patients with cerebellar degeneration. Acta Neurol. Scand. 1998.
98(5):318–323.
Ristow, M, Giannakidou, E, Hebinck, J, Busch, K, Vorgerd, M, Kotzka, J, Knebel, B, Mueller-Berghaus,
J, Epplen, C, Pfeiffer, A, Kahn, CR, Doria, A, Krone, W, Mueller-Wieland, D. An association between
NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene.
Diabetes. 1998. 47(5):851–854.
Vorgerd, M, Kubisch, C, Burwinkel, B, Reichmann, H, Mortier, W, Tettenborn, B, Pongratz, D,
Lindemuth, R, Tegenthoff, M, Malin, JP, Kilimann, MW. Mutation analysis in myophosphorylase
deficiency (McArdle's disease). Ann. Neurol. 1998. 43(3):326–331.
Vorgerd, M, Burwinkel, B, Reichmann, H, Malin, JP, Kilimann, MW. Adult-onset glycogen storage
disease type II: phenotypic and allelic heterogeneity in German patients. Neurogenetics. 1998.
1(3):205–211.
Ristow, M, Vorgerd, M, Möhlig, M, Schatz, H, Pfeiffer, A. Deficiency of phosphofructo-1-kinase/muscle
subtype in humans impairs insulin secretion and causes insulin resistance. J. Clin. Invest. 1997.
100(11):2833–2841.
Schöls, L, Gispert, S, Vorgerd, M, Menezes Vieira-Saecker, AM, Blanke, P, Auburger, G, Amoiridis, G,
Meves, S, Epplen, JT, Przuntek, H, Pulst, SM, Riess, O. Spinocerebellar ataxia type 2. Genotype and
phenotype in German kindreds. Arch. Neurol. 1997. 54(9):1073–1080.
Vorgerd, M, Tegenthoff, M, Kühne, D, Malin, JP. Spinal MRI in progressive myeloneuropathy
associated with vitamin E deficiency. Neuroradiology. 1996. 38 Suppl 1:S111-3.
Tegenthoff, M, Vorgerd, M, Juskowiak, F, Roos, V, Malin, JP. Postexcitatory inhibition after
transcranial magnetic single and double brain stimulation in Huntington's disease.
Electroencephalogr Clin Neurophysiol. 1996. 101(4):298–303.
Vorgerd, M, Karitzky, J, Ristow, M, van Schaftingen, E, Tegenthoff, M, Jerusalem, F, Malin, JP.
Muscle phosphofructokinase deficiency in two generations. J. Neurol. Sci. 1996. 1411-2:95–99.
Wessel, K, Tegenthoff, M, Vorgerd, M, Otto, V, Nitschke, MF, Malin, JP. Enhancement of inhibitory
mechanisms in the motor cortex of patients with cerebellar degeneration: a study with transcranial
magnetic brain stimulation. Electroencephalogr Clin Neurophysiol. 1996. 101(4):273–280.
Vorgerd, M, Fuchs, S, Tegenthoff, M, Malin, JP. A missense point mutation (Ser515Phe) in the
adrenoleukodystrophy gene in a family with adrenomyeloneuropathy: a clinical, biochemical, and
genetic study. J. Neurol. Neurosurg. Psychiatr. 1995. 58(2):229–231.